AzTrials
AzTrials

Psychological DistressNCT04230135

Cultural Adaptation of Hap-pas-Hapi (Step-by-Step) for Albanian-speaking Immigrants in Switzerland and Germany

A study testing Hap-pas-Hapi in people with Psychological Distress, run by University of Zurich at 2 sites in 2 countries.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

We aim to compare two different levels of cultural adaptation of an Internet- and mobile-based intervention for the treatment of depression called Hap-pas-Hapi among Albanian-speaking immigrants in Switzerland and Germany. One arm will include the generic (minimally adapted) version of Hap-pas Hapi. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychological Distress
What is being tested?
Hap-pas-Hapi
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
97 participants
Where
2 sitesin 2 countries
Study dates
15 Jun 2020to 30 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Electronic informed consent documented by time-stamped agreement to a set of consent questions
  • Albanian-speaking
  • Male and female participants aged above 18
  • Kessler Psychological Distress Scale (K10), Albanian version score >15
  • Access to Smartphone (iOS or Android) or web-browser

Who cannot join

  • People living outside Germany or Switzerland
  • Serious suicidal thoughts or plan (self-assessed with a corresponding question)

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Germany1 site
  • Freie Universität Berlin

    Berlin

Other trials in Germany

Switzerland1 site
  • University of Zurich

    Zurich, 8050

Other trials in Switzerland

About this study

Official title: Randomised Controlled Trial to Test to What Extent the Adaptation of a Smartphone-based Self-help Programme to Albanian Immigrants' Cultural Concepts of Distress Enhances Its Acceptability and Efficacy

We aim to compare two different levels of cultural adaptation of an Internet- and mobile-based intervention for the treatment of depression called Hap-pas-Hapi among Albanian-speaking immigrants in Switzerland and Germany. One arm will include the generic (minimally adapted) version of Hap-pas Hapi. The other arm will include a version of Hap-pas-Hapi that was adapted to the target population's cultural concepts of distress. Both versions include five sessions and the same therapeutic techniques.

Being tested
Hap-pas-Hapi

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hap-pas-HapiDevice

    Hap-pas-Hapi is a Smartphone-based intervention for the treatment of psychological distress. It includes five sessions and uses a narrative approach. Behavioural activation is the main active therapeutic agent in the intervention, along with stress management, positive self-talk, mood tracking, social support, and relapse prevention.

Study groups in NCT04230135
Study groupRoleWhat they receive
Generic (surface adaptation)Active comparatorThe generic version of Hap-pas-Hapi includes only surface adaptations (i.e., adaptation of text and illustrations that are inacceptable or non-meaningful for the target group)
Receives: Device: Hap-pas-Hapi
Adapted (deep structure adaptation)ExperimentalFor the experimental intervention, Hap-pas-Hapi was adapted to Albanian immigrants' cultural concepts of distress (CCD). An ethnopsychological study was conducted for this purpose, since evidence on CCD in South Eastern Europe is scarce. Based on this study, three deep-structure adaptations were done: i) the symptom narrative provided by the narrator in the app was re-written to reflect Albanian immigrants' CCD; ii) a new explanatory model builder was implemented to address the target group's fatalistic beliefs; and iii) a goal-setting task was programmed to address the target group's socio-centric notion of the self.
Receives: Device: Hap-pas-Hapi

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychological distress

    Hopkins Symptom Checklist-25 (HSCL-25)

    Measured: Six weeks

  2. Treatment adherence

    Completing at least three (out of five) sessions of Hap-pas-Hapi;

    Measured: Six weeks

Secondary outcomes (4)
  1. Functional impairment (health and disability)

    WHO Disability Assessment Schedule (WHODAS 2.0)

    Measured: Six weeks

  2. Well-being

    The WHO Wellbeing Index (WHO-5)

    Measured: Six weeks

  3. Post-traumatic stress disorder

    The PTSD checklist, 8 items version (PCL-8)

    Measured: Six weeks

  4. Self-defined problems

    The Psychological Outcome Profiles (PSYCHLOPS)

    Measured: Six weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2020
  2. Study start15 Jun 2020
  3. Primary completion31 Aug 2021
  4. Study completion30 Nov 2021

Why it stopped: An insufficient number of participants could be recruited, and drop-out rates were very high (80%)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
97 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04230135
Sponsor's protocol ID
Hap-pas-Hapi
Status last verified
May 2022
First submitted
13 Jan 2020
Last updated
25 May 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Hap-pas-Hapi in people with Psychological Distress, run by University of Zurich at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 25 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Germany, Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: An insufficient number of participants could be recruited, and drop-out rates were very high (80%)). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychological distress (time frame: Six weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in